MedKoo Cat#: 593120 | Name: Citenamide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Citenamide is an Anticonvulsant.

Chemical Structure

Citenamide
Citenamide
CAS#10423-37-7

Theoretical Analysis

MedKoo Cat#: 593120

Name: Citenamide

CAS#: 10423-37-7

Chemical Formula: C16H13NO

Exact Mass: 235.0997

Molecular Weight: 235.29

Elemental Analysis: C, 81.68; H, 5.57; N, 5.95; O, 6.80

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Citenamide
IUPAC/Chemical Name
5H-Dibenzo(a,d)cycloheptene-5-carboxamide
InChi Key
HXQAPLNYYFQSFU-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H13NO/c17-16(18)15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-10,15H,(H2,17,18)
SMILES Code
O=C(C1C2=CC=CC=C2C=CC3=CC=CC=C13)N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 235.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Johnston A, Florence AJ, Miller GJ, Kennedy AR, Bedford CT. Cytenamide-formic acid (1/1). Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 5;64(Pt 8):o1379-80. doi: 10.1107/S1600536808019181. PubMed PMID: 21203100; PubMed Central PMCID: PMC2962013. 2: Johnston A, Florence AJ, Fabbiani FJ, Shankland K, Bedford CT. Cytenamide-1,4-dioxane (2/1). Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 28;64(Pt 7):o1345-6. doi: 10.1107/S1600536808018709. PubMed PMID: 21202967; PubMed Central PMCID: PMC2961860. 3: Johnston A, Florence AJ, Fabbiani FJ, Shankland K, Bedford CT. Cytenamide-butyric acid (1/1). Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 19;64(Pt 7):o1295-6. doi: 10.1107/S1600536808018059. PubMed PMID: 21202925; PubMed Central PMCID: PMC2961685. 4: Johnston A, Florence AJ, Fabbiani FJ, Shankland K, Bedford CT, Bardin J. Cytenamide trifluoro-acetic acid solvate. Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 7;64(Pt 7):o1215-6. doi: 10.1107/S1600536808016577. PubMed PMID: 21202853; PubMed Central PMCID: PMC2961719. 5: Johnston A, Florence AJ, Fabianni FJ, Shankland K, Bedford CT. Cytenamide acetic acid solvate. Acta Crystallogr Sect E Struct Rep Online. 2008 May 30;64(Pt 6):o1175-6. doi: 10.1107/S160053680801550X. PubMed PMID: 21202682; PubMed Central PMCID: PMC2961612. 6: Frigerio A, Lanzoni J, Pantarotto C, Rossi E, Rovei V, Zanol M. Epoxide-diol metabolic pathway of cytenamide in the rat. J Chromatogr. 1977 Apr 11;134(2):299-305. PubMed PMID: 858759.